No Relationship Between Vitamin D Status and Insulin Resistance in a Group of High School Students by Erdönmez, Dilek et al.
J Clin Res Pediatr En  docrinol 2011;3(4):198-201
DO  I: 10.4274/jcrpe.507
Dilek Erdönmez, Şükrü Hatun, Filiz Mine Çizmecioğlu, Alev Keser 
Kocaeli University of Medical School, Pediatric Endocrinology and Diabetes Unit, Kocaeli, Turkey 
Ad dress  for  Cor res pon den ce
Şükrü Hatun MD, Kocaeli University of Medical School, Pediatric Endocrinology and Diabetes Unit, Kocaeli, Turkey 
Tel.: +90 262 303 87 31 E-ma  il: sukruhatun@gmail.com
© Jo  ur  nal of Cli  ni  cal Re  se  arch in Pe  di  at  ric En  doc  ri  no  logy, Pub  lis  hed by Ga  le  nos Pub  lis  hing.
No Relationship Between Vitamin D Status and Insulin
Resistance in a Group of High School Students 
Ori  gi  nal Ar  tic  le
198
In tro duc ti on
Enhancing the intestinal absorption of calcium, inhibiting
PTH gene transcription, regulating the expression of bone
matrix proteins and promoting the differentiation of
osteoclasts are some of the known effects of vitamin D (1).
Studies on vitamin D receptor (VDR) knock-out mouse
models have shown that the immune system is actually
normal in these animals, but in the presence of trigger
factors, the risk for autoimmune diseases such as type 1
diabetes mellitus and inflammatory bowel diseases
increases. These same studies have also found that in the
absence of VDRs, there is no increase in the spontaneous
occurrence of cancer spontaneously, but a tendency of the
mice to develop some tumors that are facilitated by
oncogenes and chemocarcinogens has been observed.
Additionally, a predisposition to high-renin hypertension,
cardiac hypertrophy and thrombosis is seen in the absence
of these receptors (2). In recent years, there is a growing
interest in the non-classical effects of vitamin D, which is
based on findings showing the presence of VDRs in tissues
other than bone, gut and kidneys (3). There are studies in
adults  reporting that vitamin D deficiency affects insulin
sensitivity negatively and increases the risk for type 2
diabetes mellitus (4,5,6,7). There are also some reports
showing a correlation (mild or very strong) of vitamin D
deficiency with metabolic syndrome and insulin sensitivity
in children (8,9). In this present study, the effects of vitamin
D deficiency on both insulin sensitivity and risk of metabolic
syndrome were investigated in a region which is known to
have a high incidence of vitamin D deficiency among the
adolescents (10). 
ABS TRACT
Ob jec ti ve: To investigate the effects of vitamin D deficiency on both
insulin resistance and risk of metabolic syndrome in children.  
Met hods: The study group consisted of 301 children and adolescents
with a mean age of 14.2±1.8 years. Serum 25-hydroxyvitamin D 
[25(OH)D] levels and insulin resistance indices were evaluated.
According to serum 25(OH)D levels, the subjects were classified in 3
groups. Those with levels ≤10 ng/mL were labeled as the vitamin D
deficient group (group A), those with levels of 10-20 ng/mL as the
vitamin D insufficient group (group B) and those with ≥20 ng/mL as
having normal vitamin D levels (group C). Metabolic syndrome was
defined according to the International Diabetes Federation consensus.
The participants with and without metabolic syndrome were compared
in terms of 25(OH)D levels. 
Re sults: Mean 25(OH)D level of the total group was 18.2±9.3 (2.8-72.0)
ng/mL. Distribution of individuals according to their vitamin D levels
showed that 11.6% were in  group A, 53.5% in group B, and 34.9% in
group C. The proportions of boys and girls in these categories were
22.9% and 77.1% in group A, 36.6% and 63.4% in group B, 54.3% and
45.7% in group C, respectively. There were no significant differences in
25(OH)D levels in the individuals with and without impaired fasting
glucose or impaired glucose tolerance. No relationship was observed
between insulin resistance/sensitivity indices and vitamin D status
(p>0.05). Metabolic syndrome was diagnosed in 12.3% (n=37) of the
children. There was also no difference in mean 25(OH)D levels between
individuals who had and those who did not have the metabolic
syndrome. 
Conc lu si on: In our study, no correlations were found between insulin
measurements during oral glucose tolerance test and vitamin D
deficiency. Nonetheless, more extended studies including  vitamin D
supplementation and evaluating insulin sensitivity via clamp technique
are needed to further elucidate this relationship.  
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Serum 25-hydroxyvitamin D [25(OH)D] levels and oral
glucose tolerance test (OGTT) results of 301 primary and
high school students [177 girls (59%) and 124 boys (41%)]
were evaluated at the end of the winter season. The mean
age of the subjects was 14.2±1.8 (range: 11.0-18.7) years.
Weight and height of each child were measured according
to standard methods. The study group was also assessed
for obesity and metabolic syndrome. 
All cases underwent an OGTT after an 8-12-hour
overnight fast. Insulin resistance and sensitivity indices were
calculated in all children, using the following equations:
fasting glucose/insulin ratio (FGIR) (fasting glucose/fasting
insulin), homeostasis model for assessment of insulin
resistance (HOMA-IR) [fasting glucose (nmol/L) x fasting
insulin (mIU/mL)/22.5] and quantitative insulin sensitivity
check index (QUICKI) [1/log insulin + log glucose (mg/L)]. 
According to the American Diabetes Association (ADA)
recommendations, impaired fasting glucose (IFG) is
defined as a fasting glucose of ≥100 mg/dL and impaired
glucose tolerance (IGT) is defined as a two-hour glucose
level of ≥140 mg/dL. 
A competitive protein binding assay was used to measure
25(OH)D levels in fasting serum samples (Vit D EIA kit,
Immundiagnostic, Bensheim, Germany). The normal range for
25(OH)D in this assay was set at 11-70 ng/mL and intra-and
interassay coefficients of variation (CVs) were 10.7% and
13.2%, respectively. Serum 25(OH)D levels were categorized
as follows: ≤10 ng/mL indicating vitamin D deficiency (group
A), 10-20 ng/mL indicating vitamin D insufficiency (group B),
and ≥20 ng/mL for normal vitamin D level (group C). 
Metabolic syndrome was defined according to the
International Diabetes Federation (IDF) consensus. The
relationship between vitamin D status (insufficiency, deficiency
and normal) and insulin resistance indices was evaluated. The
participants with and without metabolic syndrome were
compared in terms of 25(OH)D levels. Body mass index (BMI)
of each child was calculated as weight (kg)/height (m)2.
The data were analyzed with the Statistical Package for
the Social Sciences (SPSS Inc., Chicago), Version 11.5. A
two-sample (independent group) t-test was performed to
compare some characteristics and 25(OH)D categories
between boys and girls. The chi-square test was used to
assess the frequency differences between 25(OH)D
categories. The relationships between 25(OH)D and insulin
resistance indices were evaluated using the Pearson’s
correlation coefficient. 
A p-value of <0.05 was accepted to be statistically
significant. Data are presented as mean±SD values.
Results 
Mean BMI was 26.0±0.0 (19.3-40.3), being higher in the
girls (26.5±3.8, range: 19.9-37.7) than in the boys
(25.2±3.7, range: 19.3-40.3) (p=0.002). Mean 25(OH)D level
of the total group was 18.2±9.3 ng/mL (2.8-72.0) [20.7±9.5
ng/mL (2.8-72) in the boys and 16.4±8.8 ng/mL (6.8-72) in
the girls]. 25(OH)D levels were lower in the girls than in the
boys (p<0.001). Distribution of individuals according to
their 25(OH)D levels showed that 11.6% were in  group A,
53.5% in group B and 34.9% in group C. The proportions
of boys and girls in these categories were 22.9% and
77.1% in group A, 36.6% and 63.4% in group B, and
54.3% and 45.7% in group C, respectively. Between
groups also, vitamin D deficiency was higher in the girls
(χ2=13.662; p=0.00). There was no relationship between
degree of vitamin D deficiency and obesity (χ2=0.596;
p>0.05). IFG and IGT rates were computed as 8% (n=24)
and 5% (n=15), respectively. 
There were no significant differences in 25(OH)D levels
between subjects who had and those who did not have IFG
or IGT. Frequency of IFG was 20.8% in group A (n=5), 45.8%
in group B (n=11), and 33.8% in group C (n=8) (χ2=2.204;
p>0.05). IGT frequency in group A was 6.7% (n=1), in group
B - 40% (n=6), and in group C was 53.3% (n=8) (χ2=2.412;
p>0.05). No significant associations were found between
insulin resistance/sensitivity indices and vitamin D status
(p>0.05). These results are summarized in Tables 1 and 2.
Frequency of metabolic syndrome was found to be 12.3%
(n=37). The mean vitamin D levels were similar in subjects
with and without metabolic syndrome [20.0±13.7 ng/mL
(6.6±70) vs. 17.8±8.5 ng/mL (2.8±72)] (χ2=0.419; p>0.05).
Discussion
The role of inflammatory cytokines in the relationship
between obesity and insulin resistance is known and it is
emphasised that vitamin D modulates the production of
cytokines (11,12,13). It has been suggested that vitamin D
insufficiency decreases insulin sensitivity in this way and
also increases the risk of type 2 diabetes (14,15). However,
these associations, as well as the relationships between
severity and/or duration of vitamin D deficiency and insulin
sensitivity, are issues which are not clear and which require
further documentation (16). 
Frequency of obesity and metabolic syndrome is on the
increase among school children in Turkey (17). In addition,
vitamin D insufficiency and deficiency have been reported in
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Vitamin D Status and Insulin Resistance86.5% of school children in our region (10). In this study, we
found no association of vitamin D level with insulin resistance,
impaired glucose balance and metabolic syndrome. 
The results of the 2001-2004 National Nutrition and
Health Survey in the United States indicate that metabolic
syndrome prevalence was 3.8 fold higher among obese
adolescents whose 25(OH)D levels were lower than 
15 ng/mL as compared to those with levels higher than 
26 ng/mL (8). The results of this same survey also show,
independently of adiposity, a strong association between
low vitamin D level and metabolic syndrome as well as an
association of low vitamin D level with hypertension and
hyperglycaemia. On the other hand, another study
conducted among adolescents of French origin in Canada
failed to reveal an association between 25(OH)D level and
existence of at least two components of metabolic
syndrome (9). In this same study, it was shown that every
10 ng/mL increment in 25(OH)D level causes a mild
decrease in the fasting blood glucose levels and HOMA-IR.
As is well known, discussions and controversies about
both metabolic syndrome diagnostic criteria and evaluation
of insulin resistance continue to this day. Many researchers
agree that the calculations based on fasting blood glucose
level are inadequate to evaluate the whole body insulin
resistance (18). It must be taken into account that in the
aforementioned studies, insulin resistance was evaluated
according to fasting blood glucose levels. The golden
diagnostic method for insulin sensitivity is euglycemic
hyperinsulinemic clamp. However, insulin levels obtained
during OGTT were reported to correlate strongly with
clamp results (18,19,20). 
In conclusion, this study failed to show any relationship
between insulin sensitivity and vitamin D status.
Nonetheless, more extended studies also including  vitamin
D supplementation and evaluating insulin sensitivity via
clamp technique are needed to further elucidate this topic.
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Tab le  2. Relationships between insulin resistance indices and vitamin D status
Tab le  1. Glucose and insulin levels obtained during OGTT in children with vitamin D deficiency, vitamin D insufficiency and normal vitamin D levels 
Vitamin D Deficiency  Vitamin D Insufficiency Normal Vitamin D Total p
Group (Group A) Group (Group B) Group (Group C)
Glucose (mg/dL)
Fasting 89.3±8.2 90.3±7.0 88.3±8.6 89.5±7.8 F=2.056 p>0.05
120th minute 105.0±16.8 104.3±21.4 102.5±23.6 103.8±21.7 F=0.289 p>0.05
Insulin (µU/mL)
Fasting 10.7±3.9 10.7±5.4 10.0±5.8 10.5±5.4 F=0.612 p>0.05
30th minute 79.5±55.9 75.4±61.3 65.1±51.1 72.3±57.4 F=1.353 p>0.05
60th minute 93.3±77.1 77.7±62.9 71.9±57.5 77.5±63.0 F=1.521 p>0.05
90th minute 85.1±67.6 74.4±55.9 63.9±50.4 71.9±55.7 F=2.196 p>0.05
120th minute 61.7±36.0 66.1±49.7 64.1±52.1 64.9±49.1 F=0.139 p>0.05
Peak insulin 113.6±79.9 107.4±69.2 100±64.7 105.5±68.9 F=0.636 p>0.05
OGTT: oral glucose tolerance test
Vitamin D Deficiency  Vitamin D Insufficiency Normal Vitamin D Level  Total 
Group (Group A) Group (Group B) Group (Group C) Mean±SD 
Mean±SD Mean±SD Mean±SD  p 
HOMA-IR 2.4±1.0  2.4±1.2  2.2±1.3  2.3±1.2  F=0.82  p>0.05 
GLUCOSE0/INSULİN0 9.4±3.5 10.6±5.6 11.9±7.1  10.9±6.0  F=2.965  p>0.05 
QUICKI 0.147±0.009  0.149±0.011  0.152±0.015  0.150±0.012  F=2.774  p>0.05 
HOMA-IR: homeostasis model for assessment of insulin resistance, QUICKI: quantitative insulin sensitivity check indexReferences 
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